Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > FEI Announces NanoEx Sample Holder for In Situ Transmission Electron Microscopy: NanoEx permits observation of the effects of temperature and electrical bias on materials

Abstract:
FEI (NASDAQ: FEIC) announces the availability of the NanoEx™-i/v sample holder for atomic-resolution imaging at elevated temperatures and applied electrical bias. This new solution can be integrated with FEI's transmission electron microscopes (TEMs) to observe the effects of heating and electrical bias on nanostructured materials during in situ experiments.

FEI Announces NanoEx Sample Holder for In Situ Transmission Electron Microscopy: NanoEx permits observation of the effects of temperature and electrical bias on materials

Hillsboro, OR | Posted on May 12th, 2014

Materials scientists studying the structure-function relationship of a variety of materials, including metals, alloys, catalysts, polymers, (in) organic semiconductor devices, etc., can use the NanoEx-i/v heating component on an FEI TEM to study the material's behavior under elevated temperature conditions. The holder's use of an innovative micro-electro-mechanical system (MEMS)-based heating element enables faster, more precise heating, reduced thermal drift and improved image resolution during in situ experiments, overcoming the thermal stability limitations inherent in conventional furnace-based TEM heating holders. The holder also includes contacts to allow the application of electrical bias to the sample.

Trisha Rice, vice president and general manager, Materials Science, FEI, states, "Our customers have unique sets of needs and requirements, and we are committed to providing practical solutions for their specific application challenges. The NanoEx i/v extends that approach in the field of in situ microscopy. The holder can be used with our conventional TEMs to observe the effects of temperature and bias, as well as with our environmental TEM (ETEM) to add control of the gaseous environment."

The NanoEx i/v heating holder is optimized to accept a variety of sample geometries, from nanoparticles to thin FIB-prepared lamellae. The holder uses a small MEMS device as the heating element to quickly heat the samples inside the TEM to temperatures greater than 1000° C. The MEMS heater greatly reduces the thermal mass of the holder, reducing thermal drift and enhancing imaging and analytical spatial resolution. Faster heating, direct temperature measurement, and a known temperature distribution allow the investigator to better understand precisely what is happening at the sample. When used with FEI's ChemiSTEM™ Technology, it can provide energy-dispersive X-ray spectrometry (EDS) through a heating/biasing cycle to follow changes in elemental composition and correlate them with structural changes caused by the applied in situ stimuli. The NanoEx-i/v holder is compatible with all FEI TEM platforms, and can be operated remotely when used on the Talos™ or Titan Themis™ systems.

For more information about the NanoEx i/v heating component, please visit
www.fei.com/nanoex

####

About FEI Company
FEI Company (Nasdaq: FEIC) designs, manufactures and supports a broad range of high-performance microscopy workflow solutions that provide images and answers at the micro-, nano- and picometer scales. Its innovation and leadership enable customers in industry and science to increase productivity and make breakthrough discoveries. Headquartered in Hillsboro, Ore., USA, FEI has over 2,600 employees and sales and service operations in more than 50 countries around the world.

FEI Safe Harbor Statement

This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of the NanoEx™ -i/v TEM heating component. Factors that could affect these forward-looking statements include but are not limited to our ability to manufacture, ship, deliver and install the tools or software as expected; failure of the product or technology to perform as expected; unexpected technology problems and challenges; changes to the technology; the inability of FEI, its suppliers or project partners to make the technological advances required for the technology to achieve anticipated results; and the inability of the customer to deploy the tools or develop and deploy the expected new applications. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

For more information, please click here

Contacts:
Sandy Fewkes
(media contact)
MindWrite Communications, Inc.
+1 408 224 4024


FEI Company
Fletcher Chamberlin
(investors and analysts)
Investor Relations
+1 503 726 7710

Copyright © FEI Company

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Imaging

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

News and information

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Nanomedicine

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Automating DNA origami opens door to many new uses: Like 3-D printing did for larger objects, method makes it easy to build nanoparticles out of DNA May 30th, 2016

Announcements

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Tools

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Light can 'heal' defects in new solar cell materials: Defects in some new electronic materials can be removed by making ions move under illumination May 24th, 2016

More light on cancer: Scientists created nanoparticles to highlight cancer cells May 21st, 2016

Nanobiotechnology

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Automating DNA origami opens door to many new uses: Like 3-D printing did for larger objects, method makes it easy to build nanoparticles out of DNA May 30th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic